Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-13

FDA Approved: ZOLMITRIPTAN — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

The FDA approved Glenmark's supplemental application for zolmitriptan, a generic product. This action confirms the continued market availability of the zolmitri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN (ZOLMITRIPTAN)